GREENLIGHT CAPITAL RE LTD
For the period ended Sep 30, 2024. Filed Nov 4, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 4, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
September 30, 2024 (unaudited) and December 31, 2023
(expressed in thousands of U.S. dollars, except per share and share amounts)
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Assets | ||
| Investments | ||
| Investment in related party investment fund, at fair value | $397,888 | $258,890 |
| Other investments | 73,559 | 73,293 |
| Total investments | 471,447 | 332,183 |
| Cash and cash equivalents | 54,642 | 51,082 |
| Restricted cash and cash equivalents | 567,091 | 604,648 |
| Reinsurance balances receivable (net of allowance for expected credit losses of 2024: $865 and 2023: $854) | 718,719 | 619,401 |
| Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of 2024: $700 and 2023: $487) | 65,947 | 25,687 |
| Deferred acquisition costs | 82,206 | 79,956 |
| Unearned premiums ceded | 35,270 | 17,261 |
| Other assets | 6,364 | 5,089 |
| Total assets | $2,001,686 | $1,735,307 |
| Liabilities and equity | ||
| Liabilities | ||
| Loss and loss adjustment expense reserves | $811,152 | $661,554 |
| Unearned premium reserves | 347,103 | 306,310 |
| Reinsurance balances payable | 88,152 | 68,983 |
| Funds withheld | 20,788 | 17,289 |
| Other liabilities | 8,491 | 11,795 |
| Debt | 62,582 | 73,281 |
| Total liabilities | 1,338,268 | 1,139,212 |
| Commitments and Contingencies (Note 15) | ||
| Shareholders' equity | ||
| Preferred share capital (par value $0.10; none issued) | — | — |
| Ordinary share capital (par value $0.10; issued and outstanding, 34,832,493) (2023: par value $0.10; issued and outstanding, 35,336,732) | 3,483 | 3,534 |
| Additional paid-in capital | 481,672 | 484,532 |
| Retained earnings | 178,263 | 108,029 |
| Total shareholders' equity | 663,418 | 596,095 |
| Total liabilities and equity | $2,001,686 | $1,735,307 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the three and nine months ended September 30, 2024 and 2023
(expressed in thousands of U.S. dollars, except per share and share amounts)
| Three months ended September 30 | Nine months ended September 30 | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenues | ||||
| Gross premiums written | $168,346 | $183,074 | $554,579 | $524,472 |
| Gross premiums ceded | (26,598) | (14,789) | (64,611) | (35,740) |
| Net premiums written | 141,748 | 168,285 | 489,968 | 488,732 |
| Change in net unearned premium reserves | 10,136 | (5,175) | (18,150) | (43,030) |
| Net premiums earned | 151,884 | 163,110 | 471,818 | 445,702 |
| Income (loss) from investment in related party investment fund (net of related party expenses - Note 3) | 19,844 | (1,853) | 42,422 | 27,791 |
| Net investment income | 8,244 | 6,958 | 24,611 | 24,705 |
| Foreign exchange gains (losses) | 5,826 | (1,999) | 3,245 | 7,661 |
| Other income, net | 2,210 | 706 | 12,088 | 5,738 |
| Total revenues | 188,008 | 166,922 | 554,184 | 511,597 |
| Expenses | ||||
| Net loss and loss adjustment expenses incurred | 93,165 | 96,843 | 304,524 | 284,072 |
| Acquisition costs | 46,162 | 46,933 | 138,226 | 126,702 |
| General and administrative expenses | 10,326 | 7,905 | 31,557 | 27,866 |
| Deposit interest expense | 377 | 278 | 3,139 | 645 |
| Interest expense | 2,018 | 1,457 | 4,827 | 2,977 |
| Total expenses | 152,048 | 153,416 | 482,273 | 442,262 |
| Income before income tax | 35,960 | 13,506 | 71,911 | 69,335 |
| Income tax expense | (723) | (29) | (1,677) | (111) |
| Net income | $35,237 | $13,477 | $70,234 | $69,224 |
| Earnings per share ("EPS"): | ||||
| Basic | $1.03 | $0.40 | $2.05 | $2.03 |
| Diluted | $1.01 | $0.39 | $2.02 | $1.99 |
| Weighted average number of ordinary shares used in the determination of EPS: | ||||
| Basic | 34,120,955 | 34,070,818 | 34,210,560 | 34,067,012 |
| Diluted | 34,810,066 | 34,801,864 | 34,824,372 | 34,703,973 |
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
For the three and nine months ended September 30, 2024 and 2023
(expressed in thousands of U.S. dollars)
| Three months ended September 30 | Nine months ended September 30 | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Ordinary share capital | ||||
| Balance - beginning of period | $3,532 | $3,527 | $3,534 | $3,482 |
| Issue of ordinary shares, net of forfeitures | 6 | 7 | 4 | 52 |
| Repurchase of ordinary shares | (55) | — | (55) | — |
| Balance - end of period | 3,483 | 3,534 | 3,483 | 3,534 |
| Additional paid-in capital | ||||
| Balance - beginning of period | 487,462 | 480,648 | 484,532 | 478,439 |
| Repurchase of ordinary shares | (7,433) | — | (7,433) | — |
| Share-based compensation expense | 1,643 | 1,260 | 4,573 | 3,469 |
| Balance - end of period | 481,672 | 481,908 | 481,672 | 481,908 |
| Retained earnings | ||||
| Balance - beginning of period | 143,026 | 76,946 | 108,029 | 21,199 |
| Net income | 35,237 | 13,477 | 70,234 | 69,224 |
| Balance - end of period | 178,263 | 90,423 | 178,263 | 90,423 |
| Total shareholders' equity | $663,418 | $575,865 | $663,418 | $575,865 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the nine months ended September 30, 2024 and 2023
(expressed in thousands of U.S. dollars)
| Nine months ended September 30 | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities | ||
| Net income | $70,234 | $69,224 |
| Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities: | ||
| Income from investments in related party investment fund | (42,422) | (27,791) |
| Net realized gain on repurchases of convertible senior notes payable | — | (265) |
| Net realized and unrealized losses (gains) on other investments | 324 | 2,299 |
| Net realized and unrealized losses (gains) on derivatives | 58 | — |
| Current expected credit losses (gains) recognized on reinsurance assets | 225 | 500 |
| Share-based compensation expense | 4,577 | 3,521 |
| Accretion of debt offering costs and change in interest accruals | 1,177 | (98) |
| Net change in: | ||
| Reinsurance balances receivable | (99,329) | (135,281) |
| Loss and loss adjustment expenses recoverable | (40,474) | (15,007) |
| Deferred acquisition costs | (2,250) | (2,711) |
| Unearned premiums ceded | (18,009) | (547) |
| Loss and loss adjustment expense reserves | 149,598 | 102,766 |
| Unearned premium reserves | 40,793 | 32,762 |
| Reinsurance balances payable | 19,169 | (35,253) |
| Funds withheld | 3,499 | (8,501) |
| Other items, net | (5,200) | (248) |
| Net cash provided by (used in) operating activities | 81,970 | (14,630) |
| Cash flows from investing activities | ||
| Proceeds from redemptions of investment in Solasglas | 14,000 | 73,997 |
| Contributions to investment in Solasglas | (110,576) | (97,000) |
| Purchases of other investments | (814) | (5,545) |
| Proceeds on disposal of other investments | 168 | 6,000 |
| Net cash used in investing activities | (97,222) | (22,548) |
| Cash flows from financing activities | ||
| Proceeds from term loans | — | 74,053 |
| Repayment of term loans | (11,876) | — |
| Repayment of convertible senior notes payable | — | (62,147) |
| Repurchases of convertible senior notes payable | — | (17,198) |
| Repurchase of shares | (7,488) | — |
| Net cash used in financing activities | (19,364) | (5,292) |
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | 619 | (152) |
| Decrease in cash, cash equivalents and restricted cash | (33,997) | (42,622) |
| Cash, cash equivalents and restricted cash at beginning of the period | 655,730 | 706,548 |
| Cash, cash equivalents and restricted cash at end of the period | $621,733 | $663,926 |
| Supplementary information | ||
| Interest paid in cash | $3,825 | $3,336 |
| Income tax paid (refund received) in cash | 192 | 56 |
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2024
- ORGANIZATION AND BASIS OF PRESENTATION
Organization
Greenlight Capital Re, Ltd. (“GLRE” and, together with its wholly-owned subsidiaries, the “Company”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. The Company is a global specialty property and casualty reinsurer headquartered in the Cayman Islands. The ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”
Basis of Presentation
These unaudited condensed consolidated financial statements (the “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the U.S. Securities and Exchange Commission’s (“SEC”) instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. The financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s 2023 Form 10-K. The financial statements include the accounts of GLRE and the consolidated financial statements of its wholly-owned subsidiaries and all significant intercompany transactions and balances have been eliminated on consolidation.
In the opinion of management, these financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented. The results of operations for any interim period are not necessarily indicative of the results for a full year.
Tabular dollars are in thousands, with the exception of per share amounts or otherwise noted. All amounts are reported in U.S. dollars.
Reclassifications
Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current financial statements. The Company has reported separately the foreign exchange gains (losses) from “Other income” in the condensed consolidated statements of operations. This resulted in no change to the previously reported total revenues or net income. The Company has also included the foreign exchange gains (losses) as part of the net change in working capital in the condensed consolidated statements of cash flows. Further, the Company combined “Other assets, excluding depreciation” and “Other liabilities” and presented the sum as “Other items, net” in the condensed consolidated statements of cash flows. These changes in presentation in the condensed consolidated statements of cash flows have resulted in no change to the previously reported net cash provided by (used in) operating activities.
- SIGNIFICANT ACCOUNTING POLICIES
There were no material changes to the Company’s significant accounting policies subsequent to its 2023 Form 10-K.
Recently Issued Accounting Standards Not Yet Adopted
On November 27, 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures. The new ASU requires incremental disclosures related to a public entity’s reportable segments but does not change the definition of a segment, the method for determining segments, or the criteria for aggregating operating segments into reportable segments. This new guidance is effective for the Company’s 2024 year-end financial statements, and should be adopted retrospectively unless impracticable. Early adoption is permitted.
On December 14, 2023, FASB issued ASU 2023-09, Income Taxes Topic (740) - Improvements to Income Tax Disclosures. The new ASU provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. Early adoption is permitted. The amendments should be applied on a prospective basis; however, retrospective application is permitted. This ASU is effective for the Company’s 2024 year-end financial statements.
As the above ASUs relate solely to financial statement disclosures, the adoption of these ASUs will not impact the Company’s financial condition, results of operations, or cash flows.
- INVESTMENT IN RELATED PARTY INVESTMENT FUND
Effective August 1, 2024, the Company and Solasglas Investments, LP (“Solasglas”) entered into Amendment No. 2 to the Second Amended and Restated Exempted Limited Partnership Agreement, to revise the Investment Cap from 60% to 70% (as defined in Note 3 of the 2023 Form 10-K).
The Company’s maximum exposure to loss relating to Solasglas is limited to GLRE's share of Partners’ capital in Solasglas. At September 30, 2024, GLRE’s share of Partners’ capital in Solasglas was $397.9 million (December 31, 2023: $258.9 million), representing 77.2% (December 31, 2023:72.7%) of Solasglas’ total net assets. DME Advisors II, LLC held the remaining 22.8% (December 31, 2023:27.3%) of Solasglas’ total net assets.
The Company’s share of the net increase in Partner’s capital for the three and nine months ended September 30, 2024 was $19.8 million and $42.4 million, respectively, (three and nine months ended September 30, 2023: a net decrease of $1.9 million and a net increase of $27.8 million, respectively), as shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations.
The summarized financial statements of Solasglas are presented below.
Summarized Statements of Financial Condition of Solasglas Investments, LP
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Assets | ||
| Investments, at fair value | $549,163 | $453,358 |
| Derivative contracts, at fair value | 11,844 | 11,167 |
| Due from brokers | 210,446 | 121,754 |
| Cash and cash equivalents | 21,782 | — |
| Interest and dividends receivable | 438 | 1,143 |
| Total assets | 793,673 | 587,422 |
| Liabilities and partners’ capital | ||
| Liabilities | ||
| Investments sold short, at fair value | (263,540) | (197,571) |
| Derivative contracts, at fair value | (12,101) | (12,917) |
| Capital withdrawals payable | (1,250) | (1,000) |
| Due to brokers | — | (17,398) |
| Interest and dividends payable | (1,409) | (2,315) |
| Accrued expenses and other liabilities | (204) | (247) |
| Total liabilities | (278,504) | (231,448) |
| Partners' capital | $515,170 | $355,974 |
| GLRE’s share of Partners' capital | $397,888 | $258,890 |
Summarized Statements of Operations of Solasglas Investments, LP
| Three months ended September 30 | Nine months ended September 30 | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Investment income | ||||
| Dividend income (net of withholding taxes) | $752 | $273 | $2,524 | $1,624 |
| Interest income | 3,540 | 2,523 | 10,040 | 6,415 |
| Total Investment income | 4,292 | 2,796 | 12,564 | 8,039 |
| Expenses | ||||
| Management fee | (1,613) | (1,238) | (4,344) | (3,469) |
| Interest | (817) | (2,380) | (2,887) | (5,387) |
| Dividends | (782) | (659) | (2,217) | (1,871) |
| Professional fees and other | (262) | (507) | (921) | (1,396) |
| Total expenses | (3,474) | (4,784) | (10,369) | (12,123) |
| Net investment income (loss) | 818 | (1,988) | 2,195 | (4,084) |
| Realized and change in unrealized gains (losses) | ||||
| Net realized gain (loss) | 23,647 | 460 | 86,677 | (2,145) |
| Net change in unrealized appreciation (depreciation) | 4,801 | (1,191) | (24,582) | 52,601 |
| Net gain (loss) on investment transactions | 28,448 | (731) | 62,095 | 50,456 |
| Net increase (decrease) in Partners' capital (1) | $29,265 | $(2,719) | $64,289 | $46,372 |
| GLRE’s share of the increase (decrease) in Partners' capital | $19,844 | $(1,853) | $42,422 | $27,791 |
(1) The net increase in Partners’ capital is net of management fees and performance allocation presented below:
| Three months ended September 30 | Nine months ended September 30 | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Management fees | $1,613 | $1,238 | $4,344 | $3,469 |
| Performance allocation | 2,205 | $(206) | 4,714 | 3,088 |
| Total | $3,818 | $1,032 | $9,058 | $6,557 |
- OTHER INVESTMENTS
At September 30, 2024, the breakdown of the Company’s other investments was as follows:
| Cost | Unrealizedgains | Unrealizedlosses | Accrued interest | Fair value / carrying value | |
|---|---|---|---|---|---|
| Private investments and unlisted equities | $27,570 | $49,902 | $(5,206) | $— | $72,266 |
| Debt and convertible debt securities | 2,713 | — | (1,510) | 90 | 1,293 |
| Total other investments | $30,283 | $49,902 | $(6,716) | $90 | $73,559 |
At December 31, 2023, the breakdown of the Company’s other investments was as follows:
| Cost | Unrealizedgains | Unrealizedlosses | Accrued interest | Fair value / carrying value | |
|---|---|---|---|---|---|
| Private investments and unlisted equities | $28,470 | $49,424 | $(6,737) | $— | $71,157 |
| Debt and convertible debt securities | 2,499 | — | (499) | 136 | 2,136 |
| Total other investments | $30,969 | $49,424 | $(7,236) | $136 | $73,293 |
The following table presents the carrying values of the private investments and unlisted equity securities carried under the measurement alternative at September 30, 2024 and 2023, and the related adjustments recorded during the periods then ended.
| 2024 | 2023 | |
|---|---|---|
| Carrying value (1) | $72,266 | $64,849 |
| Upward carrying value changes (2) | $501 | $506 |
| Downward carrying value changes and impairment (3) | $— | $(2,780) |
(1) The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.
(2)The cumulative upward carrying value changes from inception to September 30, 2024, totaled $50.9 million.
(3) The cumulative downward carrying value changes and impairments from inception to September 30, 2024, totaled $2.8 million.
Net investment income
The following table summarizes the change in unrealized gains (losses) and the realized gains (losses) for the Company’s other investments, which are included in “Net investment income” in the condensed consolidated statements of operations (see Note 13):
| Three months ended September 30 | Nine months ended September 30 | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Gross realized gains | $— | $— | $— | $— |
| Gross realized losses | — | — | (1,332) | (800) |
| Net realized gains (losses) | $— | $— | $(1,332) | $(800) |
| Change in unrealized gains | — | (2,555) | 1,008 | (1,499) |
| Net realized and unrealized gains (losses) on other investments | $— | $(2,555) | $(324) | $(2,299) |
During the nine months ended September 30, 2024, the Company collected $0.2 million of liquidation proceeds relating to a private investment which was previously fully impaired, resulting in a gross realized loss of $1.3 million offset by a corresponding reduction in unrealized losses of $1.5 million. The Company also impaired $1.1 million of convertible debt securities, offset partially by favorable adjustment to the carrying value of a private investment as a result of a completed financing round by the investee.
During the three and nine months ended September 30, 2023, the Company realized a loss of $nil and $0.8 million, respectively, and a corresponding reversal of unrealized loss relating to an investment which was previously fully impaired at December 31, 2022, resulting in no impact to the Company’s net income (loss). Additionally, for the same periods, the Company recognized $2.6 million of unrealized losses on certain investments as a result of completed financing rounds by such investees.
- RESTRICTED CASH AND CASH EQUIVALENTS
The following table shows the breakdown of the Company’s restricted cash and cash equivalents, along with a reconciliation of the total cash, cash equivalents, and restricted cash reported in the condensed consolidated statements of cash flows:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Restricted cash and cash equivalents: | ||
| Cash securing trust accounts | $267,066 | $300,152 |
| Cash securing letters of credit issued | 285,775 | 291,456 |
| Cash securing Loan Facility | 10,000 | 10,000 |
| Other | 4,250 | 3,040 |
| Total restricted cash and cash equivalents | 567,091 | 604,648 |
| Cash and cash equivalents | 54,642 | 51,082 |
| Total cash, cash equivalents, and restricted cash | $621,733 | $655,730 |
- FAIR VALUE MEASUREMENTS
Assets measured at fair value on a nonrecurring basis
At September 30, 2024 and December 31, 2023, the Company held $61.8 million and $61.3 million, respectively, of private investments and unlisted equities measured at fair value on a nonrecurring basis. At September 30, 2024, the Company held $10.4 million (2023: $9.9 million) of private investments and unlisted equities measured at cost. The Company classifies these investments as Level 3 within the fair value hierarchy.
The following table summarizes the periods between the most recent fair value measurement dates and September 30, 2024, for the private and unlisted equities measured at fair value on a nonrecurring basis:
| Less than 6 months | 6 to 12 months | Over 1 year | Total | |
|---|---|---|---|---|
| Fair values measured on a nonrecurring basis | $12,434 | $7,190 | $42,223 | $61,847 |
Assets measured at fair value on a recurring basis
Derivative financial instruments
The Company uses interest rate swaps in connection with its risk management activities to hedge 50% of the interest rate risk relating to the outstanding Term Loans (see Note 9). The interest rate swaps are carried at fair value and are determined using a market approach valuation technique based on significant observable market inputs from third-party pricing vendors. Accordingly, the interest rates swaps are classified as Level 2 within the fair value hierarchy. These derivative instruments are not designated as accounting hedges under U.S. GAAP.
For the three and nine months ended September 30, 2024, the Company recognized an unrealized loss for the above derivatives of $0.6 million and $0.1 million, respectively, which is included in interest expense in the condensed consolidated statements of operations. The unrealized loss for the nine months ended September 30, 2024, is reported as “net change in unrealized gains and losses on investments and derivatives” in the condensed consolidated statements of cash flows. The derivative liability is included in other liabilities in the condensed consolidated balance sheets.
Financial Instruments Disclosed, But Not Carried, at Fair Value
At September 30, 2024, the carrying value of debt and convertible debt securities within “Other Investments” (see Note 4) and the Term Loans approximates their fair values. The Company classifies these financial instruments as Level 2 within the fair value hierarchy.
- LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES
The Company’s loss and loss adjustment expense (“LAE”) reserves were composed of the following:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Case reserves | $216,200 | $189,050 |
| IBNR | 594,952 | 472,504 |
| Total | $811,152 | $661,554 |
Reserve Roll-forward
The following provides a summary of changes in outstanding loss and LAE reserves for all lines of business:
| Consolidated | Nine months ended September 30 | |
|---|---|---|
| 2024 | 2023 | |
| Gross balance at January 1 | $661,554 | $555,468 |
| Less: Losses recoverable | (25,687) | (13,239) |
| Net balance at January 1 | 635,867 | 542,229 |
| Incurred losses related to: | ||
| Current year | 305,467 | 273,570 |
| Prior years | (943) | 10,502 |
| Total incurred | 304,524 | 284,072 |
| Paid losses related to: | ||
| Current year | (27,382) | (41,026) |
| Prior years | (176,210) | (154,374) |
| Total paid | (203,592) | (195,400) |
| Foreign currency revaluation | 8,405 | (858) |
| Net balance at September 30 | 745,205 | 630,043 |
| Add: Losses recoverable (see Note 8) | 65,947 | 28,191 |
| Gross balance at September 30 | $811,152 | $658,234 |
Estimates for Significant Catastrophe Events
At September 30, 2024, the Company’s net reserves for losses and loss expenses include estimated amounts for several catastrophe and weather-related events (“CAT loss”). The magnitude and volume of losses arising from these events is inherently uncertain and, consequently, actual losses for these events may ultimately differ, potentially materially, from current estimates.
During the nine months ended September 30, 2024, the Company recognized total CAT loss, net of reinsurance, of $48.9 million. Current year CAT loss events were $39.9 million, driven mainly by the Baltimore Bridge collapse, Hurricane Helene, and U.S. tornados (including severe convective storms). Additionally, the Company incurred $9.0 million of net adverse prior year CAT loss development relating primarily to U.S. tornados (including severe convective storms) affecting U.S. homeowners’ property coverage (2021-2023 underwriting years).
During the nine months ended September 30, 2023, the Company recognized total CAT loss, net of reinsurance, of $20.2 million. Current year CAT loss events were $29.5 million, driven mainly by the Turkey earthquake, New Zealand Cyclone Gabrielle and U.S. tornados, coupled with $9.3 million net favorable prior year CAT loss development predominantly from various prior years’ property catastrophe events (mostly 2019, 2021 and 2022 underwriting years).
Prior Year Reserve Development
During the nine months ended September 30, 2024, the Company experienced $0.9 million in net favorable development on prior year loss and LAE reserves. This was comprised of $11.4 million of favorable loss development predominantly from mortgage contracts (various underwriting years), general liability treaties (mostly 2021-2022 underwriting years), multiline commercial (predominantly 2020 underwriting year) and other specialty business (mostly 2020-2023 underwriting years). This was partially offset by $10.5 million of reserve strengthening predominantly for prior years’ CAT loss events mentioned above.
During the nine months ended September 30, 2023, the Company experienced $10.5 million in net adverse development on prior year loss and LAE reserves. This was comprised of $31.3 million of reserve strengthening predominantly on legacy motor (mainly 2021 underwriting year) and workers’ compensation (2021 and prior underwriting years) due to current economic and social inflation trends, coupled with adverse CAT loss development on U.S. homeowners’ property business relating to Winter Storm Elliott (2022 underwriting year) and a final claim settlement on a professional liability contract (2008 underwriting year). This was partially offset by $20.8 million better than expected loss emergence predominantly from the above prior years’ CAT loss events, marine and energy (predominantly 2020 and 2022 underwriting years), group medical (2022 and prior underwriting years), and cyber contracts (predominantly 2021 underwriting year).
- RETROCESSION
The following table provides a breakdown of ceded reinsurance:
| Three months ended September 30 | Nine months ended September 30 | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Gross ceded premiums | $26,598 | $14,789 | $64,611 | $35,740 |
| Earned ceded premiums | $19,512 | $15,318 | $46,603 | $35,195 |
| Loss and loss adjustment expenses ceded | $10,070 | $9,086 | $47,919 | $24,794 |
Retrocession contracts do not relieve the Company from its obligations to its cedents. Failure of retrocessionaires to honor their obligations could result in losses to the Company. The following table shows a breakdown of losses recoverable on a gross and net of collateral basis:
| September 30, 2024 · December 31, 2023 | |||||
|---|---|---|---|---|---|
| Gross · Net of Collateral(1) · Gross · Net of Collateral(1) | |||||
| A- or better by A.M. Best | $40,028 | $40,028 | $8,767 | $8,767 | |
| Not rated | 26,619 | 7,239 | 17,407 | 2,432 | |
| Total before provision | 66,647 | $47,267 | $26,174 | $11,199 | |
| Provision for credit losses | (700) | (487) | |||
| Total loss and loss adjustment expenses recoverable, net | $65,947 | $25,687 | |||
(1) Collateral is in the form of cash, letters of credit, funds withheld, and/or cash collateral held in trust accounts. This excludes any excess collateral in order to disclose the aggregate net exposure for each retrocessionaire.
At September 30, 2024, we had 3 reinsurers (December 31, 2023: 3) that accounted for 10% or more of the total loss and loss adjustment expenses recoverable, net of the credit loss provision, for an aggregate gross amount of $46.1 million (December 31, 2023: $20.4 million).
- DEBT AND CREDIT FACILITIES
Debt Obligations
The following table summarizes the Company’s outstanding debt obligations.
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Term loans | $62,187 | $74,062 |
| Accrued interest payable | 951 | — |
| Less: deferred financing costs | (556) | (781) |
| Total debt | $62,582 | $73,281 |
During the nine months ended September 30, 2024, the Company partially repaid $11.9 million of the outstanding Term loans.
Credit Facilities
At September 30, 2024, the Company had the following letter of credit (“LOC”) facilities:
| Capacity | LOCs issued | Termination Date | |
|---|---|---|---|
| Citibank Europe plc ("Citi LOC") | $229,752 | $229,752 | August 20, 2024 |
| CIBC Bank USA ("CIBC LOC") | 200,000 | 55,969 | December 21, 2024 |
| $429,752 | $285,721 |
The above LOCs issued are cash collateralized (see Note 5). The LOC facilities are subject to various customary affirmative, negative and financial covenants. At September 30, 2024, the Company was in compliance with all LOC facilities covenants.
On August 20, 2024, the $275 million committed capacity under the Citi LOC agreement was terminated, but continues to be in effect on an uncommitted basis.
- SHARE CAPITAL
Ordinary Shares
The following table is a summary of changes in ordinary shares issued and outstanding for the nine months ended September 30, 2024 and 2023:
| 2024 · 2023 | ||||
|---|---|---|---|---|
| Ordinary | Ordinary | Class A | Class B | |
| Balance – beginning of period | 35,336,732 | — | 28,569,346 | 6,254,715 |
| Issue of shares, net of forfeitures | 43,163 | 65,394 | 447,952 | — |
| Repurchase of shares | (547,402) | — | — | — |
| Re-designate Class B to Class A shares | — | — | 6,254,715 | (6,254,715) |
| Reclassify Class A to Ordinary shares | — | 35,272,013 | (35,272,013) | — |
| Balance – end of period | 34,832,493 | 35,337,407 | — | — |
The Company’s authorized share capital is 125,000,000 ordinary shares, par value of $0.10 per share.
On July 25, 2023, at the Company’s Annual General Meeting the shareholders approved the re-designation of Class B ordinary shares as Class A ordinary shares, and then reclassified Class A ordinary shares as “ordinary shares”, resulting in the elimination of the dual-class share structure.
At September 30, 2024, the Company has an effective Form S-3 registration statement on file with the SEC for an aggregate principal amount of $200.0 million in securities.
Share Repurchase Plan
On May 3, 2024, the Board of Directors re-approved the share repurchase plan, until June 30, 2025, authorizing the Company to repurchase up to $25.0 million of ordinary shares or securities convertible into ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. Any shares repurchased are canceled immediately upon repurchase. For the three and nine months ended September 30, 2024, the Company repurchased 547,402 ordinary shares for $7.5 million.
Preferred Shares
The Company’s authorized share capital also consists of 50,000,000 preference shares with a par value of $0.10 each. At September 30, 2024, the Company has no issued and outstanding preferred shares.
- SHARE-BASED COMPENSATION
Refer to Note 11 of the Company’s audited consolidated financial statements of its 2023 Form 10-K for a summary of the Company’s 2023 Incentive Plan, including the definition of performance-based and service-based stock awards.
Employee and Director Restricted Shares
The following table summarizes the activity for unvested outstanding restricted share awards (“RSs”) during the nine months ended September 30, 2024 and 2023:
| Performance Restricted Shares | Service Restricted Shares | |||
|---|---|---|---|---|
| Number ofnon-vestedrestricted shares | Weighted averagegrant datefair value | Number ofnon-vestedrestricted shares | Weighted averagegrant datefair value | |
| Balance at December 31, 2022 | 794,362 | $7.62 | 832,896 | $7.76 |
| Granted | 357,766 | 9.85 | 242,957 | 10.22 |
| Vested | — | — | (364,006) | 6.96 |
| Forfeited | (109,105) | 9.37 | (55,967) | 8.43 |
| Balance at September 30, 2023 | 1,043,023 | $8.20 | 655,880 | $9.05 |
| Balance at December 31, 2023 | 1,042,688 | $9.94 | 419,604 | $9.18 |
| Granted | — | — | 58,751 | 12.51 |
| Vested | — | — | (282,916) | 9.35 |
| Forfeited | (89,945) | 10.84 | — | — |
| Balance at September 30, 2024 | 952,743 | $9.86 | 195,439 | $9.93 |
At September 30, 2024,2,825,659 (December 31, 2023:3,296,771) ordinary shares remained available for future issuance under the Company’s 2023 Incentive Plan.
During the nine months ended September 30, 2024 , the Company grantedno RSs to employees and 58,751 RSs to non-employee directors as part of their remuneration for services to the Company (2023:535,329 RSs to employees and non-employee directors). These will vest on the earlier of (1) the first anniversary of the date of the share issuance and (ii) the Company’s next annual general meeting, subject to the grantee’s continued service with the Company. During the vesting period, non-employee directors retain voting rights on these RSs; but they are not entitled to any dividends declared until the RSs vest.
For the nine months ended September 30, 2024, the total fair value of Service RSs vested was $2.6 million (2023: $2.5 million).
Employee Restricted Stock Units
The following table summarizes the activity for unvested outstanding restricted stock units (“RSUs”) during the nine months ended September 30, 2024 and 2023:
| Performance RSUs | Service RSUs | |||
|---|---|---|---|---|
| Number ofnon-vestedRSUs | Weighted averagegrant datefair value | Number ofnon-vestedRSUs | Weighted averagegrant datefair value | |
| Balance at December 31, 2022 | 105,008 | $6.82 | 172,952 | $7.58 |
| Granted | 71,121 | 9.85 | 42,811 | 9.85 |
| Vested | — | — | (77,695) | 6.74 |
| Forfeited | — | — | (1,788) | 7.82 |
| Balance at September 30, 2023 | 176,129 | $8.04 | 136,280 | $8.76 |
| Balance at December 31, 2023 | 154,445 | $8.03 | 110,425 | $8.78 |
| Granted | 258,148 | 11.85 | 124,425 | 11.85 |
| Vested | — | — | (74,357) | 8.84 |
| Forfeited | (6,229) | 9.15 | (5,806) | 10.67 |
| Balance at September 30, 2024 | 406,364 | $10.44 | 154,687 | $11.15 |
For the awards granted during the nine months ended September 30, 2024, the Service RSUs vest evenly over three years on January 1, subject to the grantee’s continued service with the Company. If performance goals are achieved, the Performance RSUs will cliff vest at the end of athree-year performance period within a range of 50% and 200% of the awarded Performance RSUs, with a target of 100%.
For the nine months ended September 30, 2024, the total fair value of Service RSUs vested was $0.7 million (2023: $0.5 million).
Employee and Director Stock Options
During the nine months ended September 30, 2024,250,000 ordinary share purchase options were granted to the Company’s CEO, pursuant to his employment contract. These options vest 50,000 annually and expire in 10 years from the grant date. The grant date fair value of these options was $4.31 per share, based on the Black-Scholes option pricing model. The following inputs were used in this pricing model:
| Expected volatility | 36.4% |
|---|---|
| Expected term (in years) | 5 |
| Expected dividend yield | —% |
| Risk-free interest rate | 3.9% |
| Stock price at grant date | $11.20 |
Stock Compensation Expense
For the nine months ended September 30, 2024 and 2023, the Company recorded $4.6 million and $3.5 million of total stock compensation expense (net of forfeitures), respectively. The stock compensation expense is included in “General and administrative expenses” in the condensed consolidated statements of operations. Forfeiture recoveries were immaterial for both periods.
- EARNINGS PER SHARE
The following table reconciles net income and weighted average shares used in computing basic and diluted EPS for the three and nine months ended September 30, 2024 and 2023:
| Three months ended September 30 | Nine months ended September 30 | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Numerator for EPS | ||||
| Net income - basic | $35,237 | $13,477 | $70,234 | $69,224 |
| Net income - diluted | $35,237 | $13,477 | $70,234 | $69,224 |
| Denominator for EPS | ||||
| Weighted average shares outstanding - basic | 34,120,955 | 34,070,818 | 34,210,560 | 34,067,012 |
| Effect of dilutive employee and director share-based awards | 689,111 | 731,046 | 613,812 | 636,961 |
| Weighted average shares outstanding - diluted | 34,810,066 | 34,801,864 | 34,824,372 | 34,703,973 |
| Anti-dilutive stock options outstanding | 870,319 | 652,140 | 870,319 | 652,140 |
| EPS: | ||||
| Basic | $1.03 | $0.40 | $2.05 | $2.03 |
| Diluted | $1.01 | $0.39 | $2.02 | $1.99 |
- NET INVESTMENT INCOME
The following table provides a breakdown of net investment income:
| Three months ended September 30 | Nine months ended September 30 | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Interest and dividend income, net of withholding taxes and other expenses | $8,244 | $9,513 | $24,935 | $27,004 |
| Net realized and unrealized gains on other investments (see Note 4) | — | (2,555) | (324) | (2,299) |
| Net investment-related income | 8,244 | 6,958 | 24,611 | 24,705 |
| Share of Solasglas' net income (loss) (see Note 3) | 19,844 | (1,853) | 42,422 | 27,791 |
| Total investment income | $28,088 | $5,105 | $67,033 | $52,496 |
- RELATED PARTY TRANSACTIONS
Investment Advisory Agreement
There has been no change to the Company’s investment advisory agreement with Solasglas as described in its 2023 Form 10-K. Refer to Note 3 for a breakdown of management fees and performance fees for the nine months ended September 30, 2024 and 2023.
Green Brick Partners, Inc.
David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly-traded company. At September 30, 2024, Solasglas, along with certain affiliates of DME Advisors, collectively owned 23.0% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may sometimes be limited in its ability to trade GRBK shares held in Solasglas. At September 30, 2024, Solasglas held 1.3 million shares of GRBK.
Service Agreement
The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation offive thousand dollars per month (plus expenses). The agreement automatically renews annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party.
Collateral Assets Investment Management Agreement
Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the Solasglas LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.
- COMMITMENTS AND CONTINGENCIES
a) Concentration of Credit Risk
Cash and cash equivalents
The Company monitors its concentration of credit risk with financial institutions and limits acceptable counterparties based on current rating, outlook and other relevant factors.
Investments
The Company’s credit risk exposure to private debt and convertible debt securities within its “Other investments” are immaterial (see Note 4).
Reinsurance balances receivable, net
The following table shows the breakdown of reinsurance balances receivable:
| September 30, 2024 | December 31, 2023 | |||
|---|---|---|---|---|
| Amount | % | Amount | % | |
| Premiums receivable | $259,235 | 36.1% | $186,940 | 30.2% |
| Funds withheld: | ||||
| Funds held by cedants | 51,332 | 7.1% | 50,075 | 8.1% |
| Premiums held by Lloyds' syndicates | 296,152 | 41.2% | 264,278 | 42.7% |
| Funds at Lloyd’s | 110,395 | 15.4% | 115,772 | 18.6% |
| Profit commission receivable | 2,470 | 0.3% | 2,302 | 0.4% |
| Deposit assets | — | —% | 888 | 0.1% |
| Total before provision | 719,584 | 100.1% | 620,255 | 100.1% |
| Provision for expected credit losses | (865) | (0.1)% | (854) | (0.1)% |
| Reinsurance balances receivable, net | $718,719 | 100.0% | $619,401 | 100.0% |
The Company has posted deposits at Lloyd’s to support underwriting capacity for certain syndicates, including Syndicate 3456. Lloyd’s has a credit rating of “A+” (Superior) from A.M. Best, as revised in August 2024.
Premiums receivable includes a significant portion of estimated premiums not yet due. Brokers and other intermediaries are responsible for collecting premiums from customers on the Company’s behalf. The Company monitors its concentration of credit risks from brokers. The diversity in the Company’s client base limits credit risk associated with premiums receivable and funds (premiums) held by cedents. Further, under the reinsurance contracts the Company has contractual rights to offset premium balances receivable and funds held by cedants against corresponding payments for losses and loss expenses.
Loss and loss adjustment expenses recoverable, net
The Company regularly evaluates its net credit exposure to the retrocessionaires and their abilities to honor their respective obligations. See Note 8 for analysis of concentration of credit risk relating to retrocessionaires.
b) Lease Obligations
There was no material change to the Company’s operating lease agreements subsequent to its 2023 Form 10-K.
c) Litigation
From time to time, in the ordinary course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation. The outcomes of these procedures determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or collect funds owed. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the Company cannot predict the outcome of legal disputes with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition, or operating results.
- SEGMENT REPORTING
The Company hasone operating segment: Property & Casualty Reinsurance.
The following tables provide a breakdown of the Company’s gross premiums written by line and class of business, and by geographic area of risks insured for the periods indicated:
Gross Premiums Written by Line of Business
| Three months ended September 30 · Nine months ended September 30 | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2024 · 2023 · 2024 · 2023 | ||||||||
| Property | ||||||||
| Commercial | $14,794 | 8.8% | $16,105 | 8.8% | $45,030 | 8.0% | $45,236 | 8.6% |
| Motor | 189 | 0.1 | 122 | 0.1 | 344 | 0.1 | 706 | 0.1 |
| Personal | (1,358) | (0.8) | 16,713 | 9.1 | 16,204 | 2.9 | 48,718 | 9.3 |
| Total Property | 13,625 | 8.1 | 32,940 | 18.0 | 61,578 | 11.0 | 94,660 | 18.0 |
| Casualty | ||||||||
| General Liability | 28,084 | 16.7 | 31,325 | 17.1 | 83,482 | 15.1 | 79,401 | 15.1 |
| Motor Liability | 2,900 | 1.7 | 2,917 | 1.6 | 17,556 | 3.2 | 11,223 | 2.1 |
| Professional Liability (1) | 33 | — | 1,625 | 0.9 | 152 | — | 4,850 | 0.9 |
| Workers' Compensation | 939 | 0.6 | 4,484 | 2.4 | 4,319 | 0.8 | 11,542 | 2.2 |
| Multi-line (1) | 60,168 | 35.7 | 68,613 | 37.5 | 173,609 | 31.3 | 177,544 | 33.9 |
| Total Casualty | 92,124 | 54.7 | 108,964 | 59.5 | 279,118 | 50.4 | 284,560 | 54.2 |
| Other | ||||||||
| Accident & Health | 2,329 | 1.4 | 1,695 | 0.9 | 6,207 | 1.1 | 6,184 | 1.2 |
| Financial | 11,868 | 7.0 | 17,059 | 9.3 | 50,012 | 9.0 | 48,406 | 9.2 |
| Marine | 11,200 | 6.7 | 3,973 | 2.2 | 41,642 | 7.5 | 23,967 | 4.6 |
| Other Specialty | 37,200 | 22.1 | 18,443 | 10.1 | 116,022 | 21.0 | 66,695 | 12.8 |
| Total Other | 62,597 | 37.2 | 41,170 | 22.5 | 213,883 | 38.6 | 145,252 | 27.8 |
| $168,346 | 100.0% | $183,074 | 100.0% | $554,579 | 100.0% | $524,472 | 100.0% | |
(1) For the 2023 comparative periods, the Company has reclassified one treaty from Professional Liability to Multi-Line to conform with the current presentation within Casualty.
Gross Premiums Written by Geographic Area of Risks Insured
| Three months ended September 30 · Nine months ended September 30 | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2024 · 2023 · 2024 · 2023 | ||||||||
| U.S. and Caribbean | $54,359 | 32.3% | $77,274 | 42.2% | $173,519 | 31.3% | $206,714 | 39.4% |
| Worldwide (1) | 102,573 | 60.9 | 88,037 | 48.1 | 337,035 | 60.8 | 269,430 | 51.4 |
| Europe | 1,687 | 1.0 | 1,868 | 1.0 | 9,967 | 1.8 | 8,936 | 1.7 |
| Asia | 9,727 | 5.8 | 15,895 | 8.7 | 34,058 | 6.1 | 39,392 | 7.5 |
| $168,346 | 100.0% | $183,074 | 100.0% | $554,579 | 100.0% | $524,472 | 100.0% | |
(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S.
- SUBSEQUENT EVENTS
In October 2024, Hurricane Milton made landfall on the west coast of Florida. The Company’s preliminary loss estimates related to this event is in the range of $5.0 million to $15.0 million, based upon currently available information such as industry loss estimates and a high-level review of our in-force contracts. The Company will refine its estimated loss for Hurricane Milton, which will be recorded in the fourth quarter of 2024, as additional details about the event and actual level of claims emerge.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.